Global  

Biocept's newly split adjusted stock to begin trading on Nasdaq on September 8

Proactive Investors Monday, 7 September 2020
Biocept Inc (NASDAQ:BIOC) announced that its common shares will begin trading on its new split-adjusted basis on the Nasdaq in New York at the opening bell on September 8. It comes after the group's one-for-ten (ten shares combined and converted into one) reverse stock split which became effective at 5pm EST on September 4 this year. The stock will continue to trade under the ticker 'BIOC'. READ: Biocept says it has processed more than 20,000 COVID-19 specimens at its San Diego lab The company's stockholders approved the share split at Biocept's 2020 annual meeting of stockholders. The aim was to increase the firm's share price to, among things, enable it to regain compliance with the US$1.00 minimum bid price requirement for the Nasdaq listing rules. Biocept is a diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. It has recently added coronavirus (COVID-19) testing to support efforts to fight the pandemic. On August 31, it told investors it had received more than 21,000 COVID-19 specimens and processed more than 20,000 to date using RT-PCR technology at its San Diego lab. The company said it has distributed about 46,000 COVID-19 PCR specimen collection kits to-date and has around 34,000 additional collection kits assembled and available for immediate distribution. The vast majority of COVID-19 test results were reported to healthcare providers within 48 hours of receipt of the specimen. Biocept’s lab is a specialized, licensed molecular lab staff who have been trained in performing the COVID-19 testing. Contact the author at [email protected]
0
shares
ShareTweetSavePostSend
 
Video Credit: Market News Video - Published
News video: Daily Dividend Report: PLD,IBOC,HPP,BRT,MRCC

Daily Dividend Report: PLD,IBOC,HPP,BRT,MRCC 01:26

The Board of Directors of Prologis, declared a regular cash dividend for the quarter ending September 30, 2020. A dividend of $0.58 per share of the company's common stock, payable on September 30, 2020, to common stockholders of record at the close of business on September 17, 2020; and...

You Might Like


Related videos from verified sources

Pops and Flops: Nikola, AMC, and Snap Stock [Video]

Pops and Flops: Nikola, AMC, and Snap Stock

Nikola shares are popping after a massive sell-off and the fallout from its co-founder stepping away from the company after claims of sexual assault. The jump in stock price is also likely due to the..

Credit: Cheddar Inc.     Duration: 06:08Published
Daily Dividend Report: NEE,RYN,UNM,ETRN,MGEE [Video]

Daily Dividend Report: NEE,RYN,UNM,ETRN,MGEE

The board of directors of NextEra Energy, today declared a regular quarterly common stock dividend at a pre-split basis of $1.40 per share, which will be paid on a split-adjusted basis of $0.35 per..

Credit: Market News Video     Duration: 01:25Published
Daily Dividend Report: BK,KO,PPG,TXN,IDA [Video]

Daily Dividend Report: BK,KO,PPG,TXN,IDA

The Bank of New York Mellon today announced that its Board of Directors authorized dividends on its common and preferred stock. A quarterly common stock dividend of $0.31 per share will be payable on..

Credit: Market News Video     Duration: 02:11Published

Related news from verified sources

Biocept inks deal to make its Target Selector cancer assays in-network for 3M US military members, their families

Biocept Inc (NASDAQ:BIOC) (FRA:B002) has reached an agreement with Health Net Federal Services, making the firm an in-network provider of the company’s Target...
Proactive Investors

Humanigen plans 1:5 reverse stock split ahead of potential uplisting to Nasdaq exchange

Humanigen Inc (OTCMKTS:HGEN), the biotech firm focused on cancers and infectious diseases, is poised to carry out a reverse share split ahead of a potential...
Proactive Investors


Tweets about this